Sunshine Biopharma Inc (SBFM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.07% 9.4172	9.4102	8.9013	9.595	8.4352
Cost Of Revenue	5.95% 6.3436	5.9874	6.1709	6.5019	5.569
Gross Profit	10.21% 3.0735	3.4229	2.7304	3.093	2.8662
Operating Expenses	24.05% 4.1602	5.4775	4.0262	5.1308	3.9725
Benefits Costs and Expenses	8.36% 10.44	11.39	10.12	11.88	9.4178
Costs And Expenses	8.36% 10.44	11.39	10.12	11.88	9.4178
Operating Income/Loss	47.11% -1.0866	-2.0547	-1.2958	-2.0377	-1.1064
Nonoperating Income/Loss	12.46% 0.0654	0.0747	0.0758	-0.2492	0.1238
Income/Loss From Continuing Operations Before Tax	48.42% -1.0213	-1.98	-1.2199	-2.2869	-0.9826
Income Tax Expense/Benefit	34.29% -0.1374	-0.2092	-0.0402	-0.1287	0.2152
Income/Loss From Continuing Operations After Tax	50.09% -0.8838	-1.7708	-1.1798	-2.1582	-1.1978
Net Income/Loss	50.09% -0.8838	-1.7708	-1.1798	-2.1582	-1.1978
Preferred Stock Dividends And Other Adjustments	100.00% -	1.1798	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.33% 4.5559	4.4961	2.7033	0.4831	1.2676
Diluted Average Shares	166.10% -2.3827	3.6047	2.7033	-1.2569	1.2676
Basic Earnings Per Share	51.28% -0.19	-0.39	-0.44	6.29	-0.94
Diluted Earnings Per Share	134.15% 0.28	-0.82	-0.44	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	100.00% -	1.1798	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%